Downregulated miR-19b expression is closely associated with reduced phosphorylation of ERK, AKT and their effector proteins in EGFR mutant NSCLC cells (Baumgartner et al., 2018), suggesting that targeting miR-19b could potentially be alternative therapeutic methods in EGFR mutant NSCLC. This evidence concerns the gene EGFR and non-small cell lung carcinoma.